Survival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysis
Background: Cisplatin-based combination chemotherapy is standard treatment for metastatic urothelial carcinoma; however, the vast majority of patients experience disease progression. As systemic therapy alone is rarely curative for the treatment of metastatic urothelial cancer, not only are new ther...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IOS Press
2017
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/63341/1/Survival%20after%20metastasectomy%20for%20metastatic%20urothelial%20carcinoma.pdf |